Skip to content

Trueblue TBI Restricted Cash and Investments

Restricted Cash and Investments at other companies

Barrett Business Services logo
Barrett Business ServicesBBSI
AMN Healthcare logo
AMN HealthcareAMN

Other financials

Income statement

See full
Revenue$398.6M+7.6%
Gross profit$79.0M-8.5%
Operating income-$17.8M-26.4%
Net income-$19.8M-38.0%
EPS (diluted)-$0.66-37.5%

Balance sheet

See full
Cash & equivalents$24.1M+4.7%
Total debt$130.4M+13.2%
Total equity$256.1M-15.3%
Total assets$620.7M-10.4%

Cash flow

See full
Operating cash flow-$9.8M+55.8%
CapEx$2.8M-39.6%
Free cash flow-$12.6M+52.9%

Valuation

See full
Market cap$205.23M+4.8%
Enterprise value$311.53M+9.7%
P/S0.1×0.0×

Profitability

See full
Gross margin21.9%-3.7pp
Operating margin-3.1%-1.0pp
Net margin-3.2%-1.3pp
FCF margin-3.6%+0.8pp

Returns & leverage

See full
Return on equity-19.1%-6.2pp
Debt / equity0.5×+0.1×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Trueblue in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndInvestmentsNoncurrent.

The official record: Trueblue’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trueblue's restricted cash and investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trueblue's restricted cash and investments?
Trueblue (TBI) reported restricted cash and investments of $129.23M in Q1 2026.
How has Trueblue's restricted cash and investments changed year-over-year?
Trueblue's restricted cash and investments decreased by 24.1% year-over-year, from $170.21M to $129.23M.
What is the long-term trend for Trueblue's restricted cash and investments?
Over 5 years (2020 to 2025), Trueblue's restricted cash and investments has grown at a -10.7% compound annual growth rate (CAGR), from $240.53M to $136.59M.